10 NEWS
Clariant to source low-carbon ethylene
Clariant is to grow its bio-based ethylene oxide derivatives portfolio with low-carbon footprint ethylene from Austrian petrochemical firm OMV.
The two companies have
signed a letter of intent to accelerate the transition towards renewable carbon in the European ethylene supply chain. OMV started its own
renewable and circular production of chemicals and chemical feedstock at its refinery in Burghausen, Germany, back in 2021, and recently at its refinery in Schwechat, Austria. As part of their cooperation,
Clariant and OMV will explore and develop new strategies to meet sustainability targets in the ethylene supply chain. Both companies will share
their research findings, adopt a Life Cycle Assessment (LCA) methodology for unified approaches and define detailed
CO2 reduction roadmaps. This will include the joint
analysis of collaboration potential for the Ethanol-to-Ethylene (E2E) technology. “In response to increasing
consumer demand for more sustainable options, and with a particular focus on Europe, this partnership will help both companies meet their sustainability targets and deliver on the carbon reduction strategies of their customers,” Clariant said in a statement. “Today’s agreement between
the two companies is expected to help Clariant meet its ambitious absolute emissions reductions for operations and supply chain activities, as outlined in its 2030 climate targets,” it added. “Clariant’s targets, drafted
in accordance with the Science Based Targets Initiative (SBTi), aim to reduce Scope 1 and 2 absolute GHG emissions by 40% and Scope 3 greenhouse gas emissions by 14%, in the timeframe between 2019 and 2030.” “We are continuously working on solutions for our customers’ journeys towards the use of lower carbon footprint ethoxylates and this cooperation is an important step forward to reach this goal. “Renewable low-carbon
footprint ethylene from OMV will enable us to grow our bio- based ethylene oxide derivatives portfolio, as well as strengthen the supply chain with production in Europe, for Europe.”
South Korea OKs tris-biphenyl
triazine South Korea’s Ministry of Food and Drug Safety has approved the use of tris-biphenyl triazine as a UV filter in sunscreen products. Korea will allow the use of tris-
biphenyl triazine as UV filters up to a maximum concentration of 10% and is prohibited for use in aerosols, including pump sprays. In the case of nanoparticles, the median particle size must exceed 80 nm as uncoated particles and the purity must be 98% or higher. Tris-biphenyl triazine is also
known as Tinosorb A2B, developed by BASF. In a related development, Korea’s
revised Regulations on Cosmetic Safety Standards outlaws the use of lawsone-dihydroxyacetone mixture as a UV filter.
Syensqo signs MoU with Singapore biotech outfit
Solvay spin-off Syensqo has signed a memorandum of understanding (MoU) with Allozymes, a Singaporean start-up specialising in enzyme bioengineering. Allozymes has developed an
ultra-high throughput microfluidics platform for the engineering of enzymes and microbes for personal and home care. This platform, says Syensqo,
enables the rapid and cost-effective development of biomanufactured ingredients and bioprocesses, setting
a new standard for innovation and sustainability in the industry. “By combining Allozymes
technological capabilities with Syensqo’s application and market
access expertise, we are poised to create groundbreaking solutions that will not only benefit the home and personal care market but also contribute to a more sustainable future,” added Thomas Canova, head of Renewable Materials & Biotechnology growth platform at Syensqo. Syensqo said the MoU fits
with its strategic agenda of rapidly expanding its beauty speciality ingredients portfolio based on biotechnology.
It complements the company’s
recent acquisition of South Korean ceramides specialist JinYoung Bio, further solidifying its commitment to enabling sustainable and innovative care solutions. “Our partnership with Syensqo embodies our mutual commitment to a sustainable future, leveraging biotechnology to enable cleaner, greener processes, ensuring our actions today contribute to a healthier planet for future generations,” said Allozymes.
Debut expands ingredients partnership with L’Oréal
US beauty biotech outfit Debut has signed an agreement with L’Oréal to develop more than a dozen bio-identical ingredients designed to replace conventionally sourced ingredients. The conventional ingredients
are currently used in L’Oréal global beauty and personal care brands across skin, hair, colour cosmetics and fragrance.
PERSONAL CARE September 2024 As part of the agreement, San
Diego-based Debut will create new bio-based ingredients using proprietary advanced biomanufacturing processes that combine fermentation and cell-free technology to replace conventional methods. “Creating bio-identical
ingredients at scale helps preserve global biodiversity and secure
responsible ingredient supply chains while continuing to prioritize quality and product performance,” said Debut Founder and CEO Joshua Britton (pictured). Guive Balooch, global managing director of augmented beauty and open innovation at
L’Oréal, said: “Through this exciting partnership and adoption of breakthrough technology, we are
well-positioned to drive the creation of more sustainable and effective
products that meet the demands
of our consumers and fulfils our duty of care for the planet.
www.personalcaremagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
